Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer

Molecular Medicine Reports

Volumn 4, Issue 3, 2011, Pages 419-424

  Ha, Hong Koo ^a   Lee, Wan ^a   Park, Hyun Jun ^a   Lee, Sang Don ^a   Lee, Jeong Zoo ^a   Chung, Moon Kee ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

CXCL16 protein; CXCR6 protein; Neoplasm metastasis; Prostatic neoplasm

Indexed keywords

CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER; LUNG PARENCHYMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERINEURIUM; PROSTATE; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE, TUMOR; CHEMOKINES, CXC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS; RECEPTORS, CHEMOKINE; RECEPTORS, SCAVENGER; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79953775122     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.446     Document Type: Article

References (22)

1. Ha HK, Yun CJ, Lee SS, et al: Survival rates and related factors in men with hormone-refractory prostate cancer. Korean J Urol 50: 649-655, 2009.
2. Wang J, Lu Y, Koch AE, Zhang J and Taichman RS: CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway. Cancer Res 68: 10367-10376, 2008.
3. Koizumi K, Hojo S, Akashi T, Yasumoto K and Saiki I: Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer SCi 98: 1652-1658, 2007. (Pubitemid 47487897)
4. Hojo S, Koizumi K, Tsuneyama K, et al: High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Cancer Res 67: 4725-4731, 2007. (Pubitemid 46910179)
5. Ludwig A, Schulte A, Schnack C, et al: Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells. J Neurochem 93: 1293-1303, 2005. (Pubitemid 40776582)
6. Scholz F, Schulte A, Adamski F, et al. Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin. J Invest Dermatol 127: 1444-1455, 2007. (Pubitemid 46763000)
7. + T cells. J Leukoc Biol 77: 777-786, 2005. (Pubitemid 40628758)
8. Hu W, Zhen X, Xiong B, Wang B, Zhang W and Zhou W: CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells. Cancer Sci 99: 1362-1369, 2008. (Pubitemid 351761725)
9. Sobin LH and Fleming ID: TNM Classification of Malignant Tumors, 5th edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80: 1803-1804, 1997.
10. Epstein JI, Allsbrook WC Jr., Amin MB and Egevad LL: The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29: 1228-1242, 2005.
11. Zhang S, Qi L, Li M, et al: Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer. J Exp Clin Cancer Res 27: 62, 2008.
12. Balkwill F: The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14: 171-179, 2004.
13. Mochizuki H, Matsubara A, Teishima J, et al: Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis. Biochem Biophys Res Commun 320: 656-663, 2004. (Pubitemid 38887194)
14. Darash-Yahana M, Gillespie JW, Hewitt SM, et al. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers. PLoS One 4: E6695, 2009.
15. Li YM, Pan Y, Wei Y, et al: Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6: 459-469, 2004. (Pubitemid 39469982)
16. Jacobs SC: Spread of prostatic cancer to bone. Urology 21: 337-344, 1983.
17. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS and McCauley LK: Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62: 1832-1837, 2002.
18. Lu Y, Wang J, Xu Y, et al: CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro. Mol Cancer Res 6: 546-554, 2008. (Pubitemid 351521836)
19. Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A and Muschel RJ: Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 6: 100-102, 2000. (Pubitemid 30048535)
20. Hart IR and Fidler IJ: Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 40: 2281-2287, 1980.
21. Zlotnik A: Chemokines and cancer. Int J Cancer 119: 2026-2029, 2006.
22. Muller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001. (Pubitemid 32225831)